News
MLAB
137.50
+3.38%
4.49
Weekly Report: what happened at MLAB last week (0914-0918)?
Weekly Report · 3d ago
Weekly Report: what happened at MLAB last week (0907-0911)?
Weekly Report · 09/14 09:05
Mesa Laboratories Shareholders Back Board And Governance Decisions
TipRanks · 09/08 19:47
Weekly Report: what happened at MLAB last week (0831-0904)?
Weekly Report · 09/07 09:05
Weekly Report: what happened at MLAB last week (0824-0828)?
Weekly Report · 08/31 09:05
Weekly Report: what happened at MLAB last week (0817-0821)?
Weekly Report · 08/24 09:06
Mesa Laboratories Earnings Call Balances Progress And Risks
TipRanks · 08/23 00:19
Insider Shake-Up at Mesa Laboratories Signals Bold Executive Moves
TipRanks · 08/18 02:04
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript
The Motley Fool · 08/17 20:44
Weekly Report: what happened at MLAB last week (0810-0814)?
Weekly Report · 08/17 09:06
Mesa Labs price target raised to $110 from $94 at Wells Fargo
TipRanks · 08/16 13:31
Mesa Labs Price Target Raised to $110.00/Share From $94.00 by Wells Fargo
Dow Jones · 08/14 15:05
Mesa Labs Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 08/14 15:05
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110
Benzinga · 08/14 14:55
Mesa Laboratories (MLAB) Receives a Hold from Wells Fargo
TipRanks · 08/14 10:56
Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts
Simply Wall St · 08/12 00:30
Mesa Laboratories GAAP EPS of $0.49 beats by $0.49, revenue of $60.1M misses by $0.77M
Seeking Alpha · 08/10 20:34
Mesa Labs reports Q1 EPS $2.68, consensus $2.55
TipRanks · 08/10 20:10
Mesa Laboratories Q1 Adj. EPS $2.68 Beats $0.03 Estimate, Sales $60.138M Miss $60.867M Estimate
Benzinga · 08/10 20:01
*Mesa Labs 1Q Rev $60.1M >MLAB
Dow Jones · 08/10 20:01
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.